Micromolar concentrations of cis-fatty acid synergistically activate type III protein kinase C with diacylglycerol. This synergistic effect occurs at low concentrations of cis-fatty acid and diacylglycerol, and it is capable of inducing almost full activation of this protein kinase C subtype at a physiologically relevant Ca2+ concentration (2 4uM). The-synergistic activation mode can be observed even in the absence of Ca2+, but micromolar Ca2+ significantly enhances the type III protein kinase C activation. cis-Fatty acid also augments the diacylglycerol-induced activation of other subtypes (type I and II), although the effect is smaller than that observed in type III. Neither the diacylglycerol-nor the cis-fatty aciddependent mode of activation can fully activate any of these subtypes at a physiological concentration of Ca2+ (2 ftM). Our results suggest that the generation of three second messengers, i.e. the increase in intracellular Ca2+ concentration and the generation of both cis-fatty acid and diacylglycerol in the cell, may be necessary signals for protein kinase C activation, particularly for type III protein kinase C.
INTRODUCTION
It is well established that protein kinase C is a Ca2+-and phospholipid-dependent enzyme which is activated by diacylglycerol (DAG) resulting from receptor-mediated inositol phospholipid hydrolysis [1] [2] [3] . There is a mechanism, however, for the activation of protein kinase C that does not require any of these factors. cis-Fatty acids were shown to activate protein kinase C independently of DAG, Ca2' and phospholipids [4] [5] [6] [7] . In addition, a number of laboratories have shown that cis-fatty acids can potentiate DAG-induced protein kinase C activity additively or synergistically [8] [9] [10] [11] [12] . Since the individual subtypes of protein kinase C have different sensitivities for DAGs, cisfatty acids or arachidonate metabolites [6, 7, [13] [14] [15] , and since their cellular and subcellular localization is distinct [16] [17] [18] [19] [20] [21] [22] , it is suggested that each protein kinase C subtype may be regulated differently by the series of phospholipid metabolites [23, 24] . Seven protein kinase C subtypes (a, /3I, /II, y, 6,e, ) have been identified in the brain [25] . Three distinct protein kinase C fractions, types I, II and III, have been separated by hydroxyapatite column chromatography [26] [27] [28] . Type I, II and III protein kinase C have been shown to correspond to y, /1l+f/lI, and a-protein kinase C, respectively [28, 29] . To clarify the response of individual protein kinase C subtypes to the synergistic activation, we have purified these protein kinase C subtypes from rat brain and characterized them with respect to their sensitivity to cis-fatty acid and DAG. Here we report that cis-fatty acid and DAG synergistically activate type III protein kinase C at physiological concentrations of Ca2+.
EXPERIMENTAL Materials and chemicals
Histone (type III-S, Sigma), ATP, Triton X-100, leupeptin, phenylmethanesulphonyl fluoride (PMSF), dithiothreitol (DTT), 1,2-dioctanoyl-sn-glycerol (DiC8), oleic acid, arachidonic acid and other fatty acids (sodium salts) were obtained from Sigma. Dioleoylphosphatidylserine (DOPS) was purchased from Avanti Polar Lipids. [y-32P]ATP (3000 Ci/mmol) was obtained from New England Nuclear. AcA 34 was from IBF Biotechnics. All other chemicals used were reagent grade.
Purification of protein kinase C subtypes
Whole brains from 25 rats were used as a source of protein kinase C. Protein kinase C was purified by a four-step liquidchromatography procedure as described previously with modification [5] : (1) DEAE-cellulose ion exchange, (2) phenyl-Sepharose, (3) AcA 34 gel filtration and (4) phenyl-5PW h.p.l.c. column chromatography. Highly purified protein kinase C was further separated into three fractions (types I, II and III) by using a hydroxyapatite column [26, 27] connected to a f.p.l.c. system (Pharmacia) [28] . Purification procedures described below were carried out at 4 'C.
Homogenate. The 25 rats were killed by decapitation and brains were quickly removed. The fresh tissues were homogenized in 6 vol. of ice-cold buffer A (10 mM-EGTA, 2 mM-EDTA, 2 mm-DTT, 10 ,tg of leupeptin/ml, 1 mM-PMSF, 0.25 M-sucrose, 20 mM-Tris/HCl, pH 7.5) with a Teflon/glass homogenizer (12 up-and-down pre-equilibrated with 1.5 M-NaCl in buffer C. The column was washed with 10 bed vol. of the same buffer. Protein kinase C was then eluted with a linear gradient of 2.0-0 M-NaCl in 120 ml of buffer C, followed by 100 ml of buffer C at a flow rate of 80 ml/h. AcA 34 gel filtration. Fractions (50 ml) containing protein kinase C activity were collected and concentrated to 5 ml under N2 with a YM 30 membrane ultrafiltration unit (Amicon). The ultrafiltered sample was applied to an AcA 34 column (2.5 cm x 95 cm), which was previously equilibrated with buffer C, and eluted with 500 ml of the same buffer. The flow rate was set at 25 ml/h.
Phenyl-5PW chromatography. The protein kinase C fractions (50 ml) from AcA 34 were pooled, adjusted to 1.0 M-NaCl, and then loaded on to a phenyl-SPW column (0.75 cm x 7.5 cm), which was connected to f.p.l.c. and pre-equilibrated with 1.0 MNaCl in buffer C. After the column was washed with 30 ml of the same buffer, protein kinase C was eluted with a 20 ml linear gradient of 1.0-0 M-NaCl in buffer C, followed by 20 ml of buffer C.
Hydroxyapatite chromatography. The purified protein kinase C fractions (5 ml) from the phenyl-SPW column were then diluted with an equal volume of buffer D [20 mM-potassium phosphate, 10 % (v/v) glycerol, 2 mM-DTT, pH 7.5], applied to a hydroxyapatite column (Kokken, type S: 0.78 cm x 10 cm), which was connected to the f.p.l.c. system and pre-equilibrated with buffer D. The column was washed with 30 ml of the same buffer. Three protein kinase C subtypes were separated by application of a 80 ml gradient of 20-250 mM-potassium phosphate at a flow rate of 30 ml/h. Types I, II and III were eluted from the column with the gradient at 64 mm-, 84 mm-and 140 mMpotassium phosphate respectively. The purification factor for three types of protein kinase C was about 600-900-fold with a yield of 0.4-2 %. The apparent homogeneity of these three fractions was confirmed by SDS/PAGE followed by silver staining (Fig. 1 used was 100 /M, and other conditions were the same as those described for (a). increase is observed compared with that in its absence at the same concentration of oleic acid. Fig. 4 shows the dose-dependency of DiC8 for the activation of type III protein kinase C in the presence of different concentrations of oleic acid. Oleic acid greatly decreases the requirement for DiC8 for the activation of this subtype; protein kinase C activity induced by 50 ,M-DiC8 alone is equivalent to that activated by 10 Mm-DiC. + 25 Mm-oleic acid or to that by 2,UMDiC8 + 100 ,Mm-oleic acid. Conversely, an increase in DiC8 concentration also decreases the requirement for cis-fatty acid for the activation; the activity attained in the presence of 10O MMoleic acid + 10 jiM-DiC. is equal to that activated by 25 ,uM-oleic acid + 50 pM-DiCS. It is thus apparent that the concentration of cis-fatty acid required for the synergistic activation of type III protein kinase C is dependent on the DAG concentration.
Differential response of protein kinase C subtypes to the synergistic activation by cis-fatty acid and DAG Three protein kinase C subtypes were compared with respect to their sensitivities to the synergistic activation mode. Arachidonic acid, an w -6 cis-fatty acid and a precursor of the biologically important eicosanoids, also activates type III protein kinase C synergistically with DAG at a physiologically relevant concentration of Ca2l. As shown in Fig. 5(c) , type III protein kinase C is strongly activated by arachidonic acid and DiC8, whereas arachidonic acid or DiC8 alone has little effect at 2 ,MCa2l.. At 50 ,UM, arachidonic acid induces almost full activation, with half-maximal activation at 17 ,M in the presence of 10 ,MDiC8 (Fig. 5f) [7] , which was shown to be highly sensitive to arachidonic acid in the absence of Ca2l.
Vol. 282 Ca2l-dependency of type III protein kinase C We first characterized the Ca2+-dependency of the cis-fatty acid activation of the three subtypes in the absence of DAG.
Because the Ca2+-independence of cis-fatty acid action on protein kinase C has been shown for the mixture of protein kinase C subtypes, it is possible that some of the subtypes may be Ca2+-dependent. Activation of the protein kinase C subtypes by cisfatty acid (arachidonic acid and oleic acid) in the presence and absence of Ca2+ is shown in Fig. 6 The DAG-induced protein kinase C activation mode requires Ca2+ [1] [2] [3] , whereas Ca2+ is not necessary for the cis-fatty acid activation of protein kinase C, although type III protein kinase C activation by cis-fatty acid is more sensitive to Ca2+ than is that of other subtypes. We examined whether the synergism induced by cis-fatty acid and DAG requires Ca2+ or not. As shown in Fig.  7 , the synergistic activation does not require Ca2+. Type III protein kinase C is activated even without Ca2+ when both DAG and cis-fatty acid are present. However, micromolar concentrations of Ca2+ significantly enhance the protein kinase C activity induced by DAG and cis-fatty acid, with a Ka for Ca2+ of 2.5 UM. At higher concentrations of Ca2+ (> IO #M), the protein kinase C activity is slightly inhibited.
DISCUSSION
In this study, we have characterized the synergistic activation of protein kinase C subtypes purified from rat brain. Our results show that cis-fatty acid and DAG synergistically activate type III protein kinase C. This mode of activation is distinct from the previously reported cis-fatty acid activation of protein kinase C in several aspects. First, unlike PS/Ca2+/DAG-independent cisfatty acid activation, the synergistic activation mode is extremely sensitive to micromolar concentrations of Ca2+. (Fig. 2) and DAG (Fig. 3 ). This suggests that the site of the synergistic activation is not in the cytosol, but is rather associated with the membrane phospholipids. It has been shown that the penetration of cis-fatty acid into the phospholipid layer is much greater than that of elaidic acid (trans-isomer of oleic acid) or of saturated fatty acid, which are inactive for protein kinase C activation [35] . The mechanism of the synergistic effect in vitro is unclear at present. However, it is apparent that cis-fatty acid does not competitively bind the same domain of protein kinase C as DAG for the activation, at least in type III enzyme; a synergistic increase in Vmax would not be expected if cis-fatty acid and DAG activate protein kinase C by a competitive mechanism. This is consistent with the observations that DAG inhibits phorbol ester binding in a competitive manner [36, 37] whereas cis-fatty acid inhibition does not appear to be competitive [37] . Ono et al. [38] have shown, using various deletions, and point mutations of protein kinase C, that cysteine-rich domain in conserved region, Cl, is involved in phorbol ester binding and that another conserved region, C2, in the regulatory domain appears to regulate the Ca2+-dependency of phorbol ester binding. The C2 region has also been suggested to be important for phospholipid binding to protein kinase C [39] . It was indicated that a monomeric form of cis-fatty acid interacts with protein kinase C [5] , but the cis-fatty acid binding domain is not known. Studies using recombinant protein kinase C mutants engineered by molecular-biological techniques would provide more detailed topographical and mechanistic insights for the synergism of cisfatty acid and DAG.
Using a protein kinase C mixture preparation from rat brain, Seifert et al. [9] have shown that various unsaturated fatty acids, including some trans-fatty acids, can potentiate DAG/phospholipid-induced protein kinase C activity. It has been reported that trans-fatty acids containing two double bonds, such as linolelaidic acid, activate protein kinase C in the presence of DAG [9] . We have found that, of the trans-and saturated fatty acids tested, linolelaidic acid was also potent for the synergistic activation of type III protein kinase C. Elaidic acid also supported the synergistic activation, but to a much lesser extent, whereas saturated fatty acids such as stearic acid had no effect (results not shown). It has also been shown that protein kinase C purified from platelet cytosol, enriched in the a-isoform, is synergistically activated by oleic acid and DAG in the presence of high (300 ,aM) concentration of free Ca2+ [10] . Our [28, 29] . Another class of protein kinase C subtypes (d, e, ) has been cloned, but they have escaped biochemical detection, presumably owing to the different activation mechanism or substrate specificity [40] . However, we cannot rule out the possibility that our purified protein kinase C may contain these subtypes. We therefore used the chromatographic designation (type I, II and III) in this study.
The physiological significance of the synergism between unsaturated fatty acid and DAG has been shown, and their effects have been attributed to the activation of protein kinase C. In human lymphocytes, Szamel et al. [41] have shown that cis-fatty acids (linoleic acid and arachidonic acid) regulate interleukin 2 synthesis by inducing a prolonged protein kinase C translocation from the cytosol to the membrane in the presence of Ca2+ ionophore and DiC8, whereas these compounds alone have no such effect. They have also shown that DAG and cis-fatty acid induce protein kinase C translocation with a different temporal sequence; the former is transient, whereas the latter is longlasting. They suggested that the incorporation of polyunsaturated fatty acids into plasma-membrane phospholipids is a signal for sustained protein kinase C activation. In human platelets, Seifert et al. [42] have demonstrated that DAG-induced activation of the platelets was enhanced by unsaturated fatty acids (arachidonic acid, linoleic acid and linolelaidic acid) and that the effect was reversed by polymyxin B, a protein kinase C inhibitor. They have suggested that fatty acids and DAG may synergistically be involved in hormonal activation of protein kinase C. Since type III protein kinase C has been shown to be highly expressed in both human lymphoma [43] and platelets [44] , it is possible that the activation of these cells by cis-fatty acid and DAG is mediated by the synergistic activation of type III protein kinase C.
Arachidonic acid release and inositol phospholipid hydrolysis are often stimulated concomitantly when cells are exposed to Ca2+-mobilizing agents such as muscarinic, a1-adrenergic or peptidergic agonists in various tissues and cells (for review, see [45] ). This concomitant generation of DAG and arachidonic acid (and possibly other cis-fatty acids) may be regulated by receptormediated activation of phospholipases. In thyroid cells, oa,-adrenergic-receptor activation has been shown to stimulate both phospholipase A2 (arachidonic acid release) and phospholipase C (DAG formation) through distinct G-proteins [46] . Alternatively, DAG and cis-fatty acid may act as regulators of phospholipase A2 and C respectively. DAG has been shown to stimulate arachidonic acid metabolism in 3T3 fibroblasts [47] .It has been further demonstrated that DAG can directly activate isolated phospholipase A2 from the same cell line [48] . Conversely, arachidonic acid is capable of stimulating the inositol lipid breakdown and DAG formation in the 3T3 fibroblasts [49] . cisFatty acid has been shown to activate directly phosphatidylinositol-specific phospholipase C isolated from rat brain [50] . These cellular events may be responsible for the synergistic activation of type III protein kinase C described here. In conclusion, our results show that three second messengers, i.e. Ca2", cis-fatty acid and DAG, are necessary for the full activation of this protein kinase C subtype.
